%PDF-1.6
%
1 0 obj
<>
endobj
2 0 obj
<>stream
David Cherney, Bruce A. Perkins, Yuliya Lytvyn, Hiddo Heerspink, María E. Rodríguez-Ortiz, Harald Mischak
The effect of sodium/glucose cotransporter 2 (SGLT2) inhibition on the urinary proteome
www.plosone.org
www.plosone.org
endstream
endobj
3 0 obj
<>/XObject<>>>/CropBox[0 0 612 792]/MediaBox[0 0 612 792]/Parent 12 0 R/Annots 13 0 R/Contents 14 0 R/TrimBox[0 0 612 792]>>
endobj
13 0 obj
[15 0 R 16 0 R 17 0 R 18 0 R 19 0 R 20 0 R 21 0 R 22 0 R 23 0 R 24 0 R 25 0 R 26 0 R 27 0 R 28 0 R 29 0 R 30 0 R 31 0 R 32 0 R 33 0 R 34 0 R 35 0 R]
endobj
15 0 obj
<>/Border[0 0 0]/Dest(Rpone.0186910.ref005)>>
endobj
16 0 obj
<>/Border[0 0 0]/Dest(Rpone.0186910.ref006)>>
endobj
17 0 obj
<>/Border[0 0 0]/Dest(Rpone.0186910.ref007)>>
endobj
18 0 obj
<>/Border[0 0 0]/Dest(Rpone.0186910.ref008)>>
endobj
19 0 obj
<>/Border[0 0 0]/Dest(Rpone.0186910.ref009)>>
endobj
20 0 obj
<>/Border[0 0 0]/Dest(Rpone.0186910.ref010)>>
endobj
21 0 obj
<>/Border[0 0 0]/Dest(Rpone.0186910.ref011)>>
endobj
22 0 obj
<>/Border[0 0 0]/Dest(Rpone.0186910.ref012)>>
endobj
23 0 obj
<>/Border[0 0 0]/Dest(Rpone.0186910.ref012)>>
endobj
24 0 obj
<>/Border[0 0 0]/Dest(Rpone.0186910.ref013)>>
endobj
25 0 obj
<>/Border[0 0 0]/Dest(Rpone.0186910.ref014)>>
endobj
26 0 obj
<>/Border[0 0 0]/Dest(Rpone.0186910.ref015)>>
endobj
27 0 obj
<>/Border[0 0 0]/Dest(Rpone.0186910.ref015)>>
endobj
28 0 obj
<>/Border[0 0 0]/Dest(Rpone.0186910.ref016)>>
endobj
29 0 obj
<>/Border[0 0 0]/Dest(Rpone.0186910.ref017)>>
endobj
30 0 obj
<>/Border[0 0 0]/Dest(Rpone.0186910.ref009)>>
endobj
31 0 obj
<>/Border[0 0 0]/Dest(Rpone.0186910.ref018)>>
endobj
32 0 obj
<>/Border[0 0 0]/Dest(Rpone.0186910.ref008)>>
endobj
33 0 obj
<>/Border[0 0 0]/Dest(Rpone.0186910.ref008)>>
endobj
34 0 obj
<>/Border[0 0 0]/Dest(Rpone.0186910.ref019)>>
endobj
35 0 obj
<>/Border[0 0 0]/A 36 0 R>>
endobj
36 0 obj
<>
endobj
14 0 obj
[37 0 R 38 0 R 39 0 R 40 0 R 41 0 R 42 0 R 43 0 R 44 0 R 45 0 R 46 0 R 47 0 R 48 0 R 49 0 R 50 0 R 51 0 R 52 0 R 53 0 R 54 0 R 55 0 R 56 0 R]
endobj
37 0 obj
<>stream
q
0.83 0.64 0.02 0 k
418.2236 667.3323 m
422.9858 667.3323 l
h
f*
420.378 641.3102 m
425.1402 641.3102 l
h
f*
503.6031 641.3102 m
508.3654 641.3102 l
h
f*
296.9008 615.3449 m
301.663 615.3449 l
h
f*
328.0252 602.3055 m
332.7874 602.3055 l
h
f*
494.4756 589.3228 m
503.9433 589.3228 l
h
f*
238.6205 537.3354 m
248.1449 537.3354 l
h
f*
305.348 421.1717 m
314.8724 421.1717 l
h
f*
413.9717 395.2063 m
423.4961 395.2063 l
h
f*
387.6094 323.0362 m
397.1339 323.0362 l
h
f*
534.1039 310.0535 m
543.6283 310.0535 l
h
f*
345.0898 284.0315 m
354.5575 284.0315 l
h
f*
506.8346 271.0488 m
516.3591 271.0488 l
h
f*
343.1622 245.0835 m
352.6866 245.0835 l
h
f*
354.8976 245.0835 m
364.422 245.0835 l
h
f*
358.0724 232.0441 m
362.8346 232.0441 l
h
f*
502.1291 219.0614 m
511.5969 219.0614 l
h
f*
414.085 180.0567 m
418.8472 180.0567 l
h
f*
501.8457 167.074 m
506.6079 167.074 l
h
f*
384.6614 107.9433 m
394.1291 107.9433 l
h
f*
0 g
1 j
1 J
0 w
10 0 0 10 200.0125 707.4141 cm
BT
/F7 1 Tf
1 TL
-0.004 Tc
0 0 Td
(considerable)Tj
5.261 0 Td
(variability,)Tj
4.4447 0 Td
(this)Tj
1.6724 0 Td
(variability)Tj
4.2236 0 Td
(can)Tj
1.6271 0 Td
(be)Tj
1.1509 0 Td
(counteracted)Tj
5.4255 0 Td
(by)Tj
1.1792 0 Td
(employing)Tj
4.473 0 Td
(high-dimensional)Tj
-29.4574 -1.3039 Td
(classifiers.)Tj
4.2462 0 Td
(In)Tj
1.1112 0 Td
(such)Tj
2.0579 0 Td
(an)Tj
1.2019 0 Td
(approach,)Tj
4.1783 0 Td
(multiple)Tj
3.5659 0 Td
(biomarkers)Tj
4.7792 0 Td
(are)Tj
1.4457 0 Td
(combined)Tj
4.2462 0 Td
(in)Tj
1.0375 0 Td
(a)Tj
0.652 0 Td
(predefined)Tj
4.541 0 Td
(model,)Tj
-33.063 -1.2982 Td
(reducing)Tj
3.7757 0 Td
(and)Tj
1.7291 0 Td
(combining)Tj
4.5751 0 Td
(the)Tj
1.4683 0 Td
(biomarkers)Tj
4.7792 0 Td
(into)Tj
1.8368 0 Td
(one)Tj
1.7008 0 Td
(variable)Tj
3.3562 0 Td
(expressing)Tj
4.4277 0 Td
(the)Tj
1.4683 0 Td
(probability)Tj
4.5978 0 Td
(of)Tj
1.0148 0 Td
(the)Tj
-34.7298 -1.2983 Td
(membership)Tj
5.2553 0 Td
(in)Tj
1.0319 0 Td
(a)Tj
0.6519 0 Td
(specific)Tj
3.1861 0 Td
(group)Tj
2.6022 0 Td
(\(e.g.)Tj
1.8992 0 Td
(healthy)Tj
3.1295 0 Td
(or)Tj
1.0941 0 Td
(CKD\))Tj
2.6306 0 Td
([)Tj
0.83 0.64 0.02 0 k
(5)Tj
0 g
(].)Tj
1.5987 0 Td
(We)Tj
1.6044 0 Td
(have)Tj
2.0579 0 Td
(previously)Tj
4.3483 0 Td
(developed)Tj
4.2633 0 Td
(capil-)Tj
-35.3534 -1.2983 Td
(lary)Tj
1.7234 0 Td
(electrophoresis)Tj
6.2532 0 Td
(coupled)Tj
3.3902 0 Td
(to)Tj
1.0261 0 Td
(mass)Tj
2.194 0 Td
(spectrometry)Tj
5.4879 0 Td
(\(CE-MS\))Tj
3.8551 0 Td
(for)Tj
1.3833 0 Td
(the)Tj
1.474 0 Td
(routine)Tj
3.1634 0 Td
(application)Tj
4.6772 0 Td
(in)Tj
1.0374 0 Td
(the)Tj
-35.6652 -1.3039 Td
(assessment)Tj
4.6091 0 Td
(of)Tj
1.0148 0 Td
(clinically)Tj
3.7757 0 Td
(relevant)Tj
3.4242 0 Td
(samples,)Tj
3.6057 0 Td
(mostly)Tj
2.9083 0 Td
(urine)Tj
2.3584 0 Td
([)Tj
0.83 0.64 0.02 0 k
(6)Tj
0 g
(])Tj
1.3776 0 Td
(and)Tj
1.7291 0 Td
(dialysis)Tj
3.1351 0 Td
(fluid)Tj
2.0807 0 Td
([)Tj
0.83 0.64 0.02 0 k
(7)Tj
0 g
(].)Tj
1.5987 0 Td
(The)Tj
1.7858 0 Td
(results)Tj
-33.4032 -1.2982 Td
(demonstrated)Tj
5.7599 0 Td
(that)Tj
1.7802 0 Td
(analysis)Tj
3.3221 0 Td
(of)Tj
1.0148 0 Td
(the)Tj
1.474 0 Td
(urinary)Tj
3.1918 0 Td
(proteome)Tj
4.0876 0 Td
(enables)Tj
3.1634 0 Td
(discrimination)Tj
6.1285 0 Td
(between)Tj
3.5263 0 Td
(patients)Tj
-33.4486 -1.2983 Td
(with)Tj
1.9955 0 Td
(and)Tj
1.7292 0 Td
(without)Tj
3.3335 0 Td
(CKD)Tj
2.2904 0 Td
([)Tj
0.83 0.64 0.02 0 k
(8)Tj
0 g
(],)Tj
1.6044 0 Td
(as)Tj
1.0147 0 Td
(well)Tj
1.8199 0 Td
(as)Tj
1.0148 0 Td
(prediction)Tj
4.371 0 Td
(of)Tj
1.0148 0 Td
(progression)Tj
4.9209 0 Td
(of)Tj
1.0148 0 Td
(CKD,)Tj
2.5171 0 Td
(irrespective)Tj
4.8246 0 Td
(of)Tj
1.0148 0 Td
(the)Tj
-34.4804 -1.3039 Td
(underlying)Tj
4.5977 0 Td
(disease)Tj
3.0217 0 Td
(mechanism)Tj
4.8416 0 Td
([)Tj
0.83 0.64 0.02 0 k
(9)Tj
0 g
(].)Tj
1.6044 0 Td
(The)Tj
1.7801 0 Td
(CE-MS)Tj
3.1691 0 Td
(technology)Tj
4.6261 0 Td
(is)Tj
0.8448 0 Td
(especially)Tj
4.0195 0 Td
(well)Tj
1.8198 0 Td
(suited)Tj
2.6249 0 Td
(to)Tj
1.0261 0 Td
(assess)Tj
-33.9758 -1.2983 Td
(small)Tj
2.3243 0 Td
(proteins)Tj
3.515 0 Td
(and)Tj
1.7291 0 Td
(peptides,)Tj
3.7814 0 Td
(without)Tj
3.3335 0 Td
(the)Tj
1.4684 0 Td
(requirement)Tj
5.1987 0 Td
(of)Tj
1.0148 0 Td
(tryptic)Tj
2.8516 0 Td
(digestion)Tj
3.8891 0 Td
([)Tj
0.83 0.64 0.02 0 k
(10)Tj
0 g
(].)Tj
-27.9097 -1.2983 Td
(The)Tj
1.7858 0 Td
(aim)Tj
1.7404 0 Td
(of)Tj
1.0148 0 Td
(this)Tj
/F11 1 Tf
1.6725 0 Td
[()4()7()9()6()4()]TJ
/F7 1 Tf
(,)Tj
3.6907 0 Td
(exploratory)Tj
4.8132 0 Td
(analysis)Tj
3.3278 0 Td
(was)Tj
1.6951 0 Td
(to)Tj
1.0261 0 Td
(investigate)Tj
4.4618 0 Td
(if)Tj
0.7766 0 Td
(treatment)Tj
4.1329 0 Td
(with)Tj
2.0013 0 Td
(empagli-)Tj
-33.3352 -1.3039 Td
(flozin)Tj
2.4888 0 Td
(impacts)Tj
3.3391 0 Td
(the)Tj
1.4684 0 Td
(urinary)Tj
3.1974 0 Td
(peptidome,)Tj
4.7452 0 Td
(with)Tj
2.0013 0 Td
(a)Tj
0.6519 0 Td
(special)Tj
2.8913 0 Td
(emphasis)Tj
3.9345 0 Td
(on)Tj
1.2756 0 Td
(urinary)Tj
3.1918 0 Td
(peptide)Tj
3.1974 0 Td
(biomarkers)Tj
-32.3827 -1.2982 Td
(associated)Tj
4.2576 0 Td
(with)Tj
1.9955 0 Td
(CKDspecifically)Tj
7.1603 0 Td
(the)Tj
1.474 0 Td
(CKD273)Tj
3.719 0 Td
(biomarker,)Tj
4.6432 0 Td
(which)Tj
2.6475 0 Td
(is)Tj
0.8504 0 Td
(associated)Tj
4.2576 0 Td
(with)Tj
1.9956 0 Td
(CKD)Tj
2.2904 0 Td
(pro-)Tj
-35.2911 -1.2983 Td
(gression)Tj
3.5206 0 Td
([)Tj
0.83 0.64 0.02 0 k
(11)Tj
0 g
(].)Tj
2.0806 0 Td
(Such)Tj
2.1713 0 Td
(an)Tj
1.2019 0 Td
(impact)Tj
2.982 0 Td
(could)Tj
2.4548 0 Td
(serve)Tj
2.2507 0 Td
(as)Tj
1.0148 0 Td
(indicative)Tj
4.1329 0 Td
(of)Tj
1.0148 0 Td
(a)Tj
0.6519 0 Td
(potential)Tj
3.7644 0 Td
(benefit)Tj
2.9764 0 Td
(of)Tj
1.0148 0 Td
(empagliflozin)Tj
-31.2319 -1.3039 Td
(prior)Tj
2.2506 0 Td
(to)Tj
1.0262 0 Td
(onset)Tj
2.3584 0 Td
(of)Tj
1.0148 0 Td
(CKD,)Tj
2.5171 0 Td
(and)Tj
1.7348 0 Td
(as)Tj
1.0148 0 Td
(potential)Tj
3.7587 0 Td
(evidence)Tj
3.7134 0 Td
(for)Tj
1.3833 0 Td
(the)Tj
1.4683 0 Td
(use)Tj
1.5364 0 Td
(of)Tj
1.0148 0 Td
(empagliflozin)Tj
5.6636 0 Td
(in)Tj
1.0318 0 Td
(the)Tj
1.474 0 Td
(prevention)Tj
-32.961 -1.2983 Td
(of)Tj
1.0147 0 Td
(DKD)Tj
2.3641 0 Td
(onset)Tj
2.3584 0 Td
(and)Tj
1.7292 0 Td
(progression.)Tj
ET
Q
q
1 j
1 J
0 w
11.9999 0 0 11.9999 200.0125 483.2503 cm
BT
/F2 1 Tf
1 TL
-0.0033 Tc
0 0 Td
(Materials)Tj
4.5071 0 Td
(and)Tj
1.989 0 Td
(methods)Tj
/F0 1 Tf
-6.4961 -1.4976 Td
(Patients)Tj
3.7937 0 Td
(and)Tj
1.8661 0 Td
(sample)Tj
3.4016 0 Td
(collection)Tj
ET
Q
q
1 j
1 J
0 w
10 0 0 10 200.0125 448.2708 cm
BT
/F7 1 Tf
1 TL
-0.004 Tc
0 0 Td
(Samples)Tj
3.4979 0 Td
(were)Tj
2.1203 0 Td
(collected)Tj
3.7417 0 Td
(as)Tj
1.0148 0 Td
(described)Tj
4.0478 0 Td
(in)Tj
1.0375 0 Td
(previous)Tj
3.651 0 Td
(work)Tj
2.2791 0 Td
(during)Tj
2.9253 0 Td
(clamped)Tj
3.6113 0 Td
(euglycemia)Tj
4.7055 0 Td
(and)Tj
1.7348 0 Td
(hyper-)Tj
-34.367 -1.2982 Td
(glycemia)Tj
3.753 0 Td
(in)Tj
1.0375 0 Td
(uncomplicated)Tj
6.1795 0 Td
(patients)Tj
3.3732 0 Td
(with)Tj
1.9955 0 Td
(T1D)Tj
2.041 0 Td
(before)Tj
2.7439 0 Td
(and)Tj
1.7291 0 Td
(after)Tj
2.0353 0 Td
(treatment)Tj
4.1329 0 Td
(with)Tj
2.0012 0 Td
(empagliflozin)Tj
-31.0221 -1.3039 Td
(\(25)Tj
1.508 0 Td
(mg)Tj
1.508 0 Td
(daily\))Tj
2.4888 0 Td
(for)Tj
1.3833 0 Td
(8)Tj
0.6973 0 Td
(weeks)Tj
2.6079 0 Td
([)Tj
0.83 0.64 0.02 0 k
(12)Tj
0 g
(].)Tj
2.0806 0 Td
(All)Tj
1.3946 0 Td
(patients)Tj
3.3676 0 Td
(consented)Tj
4.2803 0 Td
(to)Tj
1.0261 0 Td
(the)Tj
1.4683 0 Td
(study,)Tj
2.6192 0 Td
(which)Tj
2.6476 0 Td
(was)Tj
1.7007 0 Td
(approved)Tj
3.9742 0 Td
(by)Tj
1.1792 0 Td
(the)Tj
-35.9317 -1.2983 Td
(University)Tj
4.3993 0 Td
(of)Tj
1.0148 0 Td
(Toronto)Tj
3.5716 0 Td
(University)Tj
4.405 0 Td
(Health)Tj
2.914 0 Td
(Network)Tj
3.7361 0 Td
(with)Tj
2.0012 0 Td
(approval)Tj
3.702 0 Td
(#110213.)Tj
4.2917 0 Td
(The)Tj
1.7801 0 Td
(available)Tj
3.668 0 Td
(clini-)Tj
-35.4838 -1.2983 Td
(cal)Tj
1.3209 0 Td
(and)Tj
1.7291 0 Td
(demographic)Tj
5.5049 0 Td
(data)Tj
1.9162 0 Td
(were)Tj
2.1203 0 Td
(presented)Tj
4.1158 0 Td
(previously)Tj
4.354 0 Td
([)Tj
0.83 0.64 0.02 0 k
(12)Tj
0 g
(].)Tj
ET
Q
q
1 j
1 J
0 w
11.9999 0 0 11.9999 200.0125 367.1433 cm
BT
/F0 1 Tf
1 TL
-0.0033 Tc
0 0 Td
(Urinary)Tj
3.4016 0 Td
(proteome)Tj
4.3984 0 Td
(analysis)Tj
3.7843 0 Td
(and)Tj
1.8614 0 Td
(peptide)Tj
3.4583 0 Td
(identification)Tj
ET
Q
q
1 j
1 J
0 w
10 0 0 10 200.0125 350.1354 cm
BT
/F7 1 Tf
1 TL
-0.004 Tc
0 0 Td
(The)Tj
1.7801 0 Td
(urine)Tj
2.3584 0 Td
(samples)Tj
3.3846 0 Td
(were)Tj
2.1203 0 Td
(prepared)Tj
3.8097 0 Td
(and)Tj
1.7291 0 Td
(analyzed)Tj
3.702 0 Td
(using)Tj
2.3868 0 Td
(a)Tj
0.6576 0 Td
(P/ACE)Tj
3.0217 0 Td
(MDQ)Tj
2.5966 0 Td
(capillary)Tj
3.6169 0 Td
(electrophoresis)Tj
-31.1638 -1.2982 Td
(system)Tj
2.9366 0 Td
(\(Beckman)Tj
4.286 0 Td
(Coulter,)Tj
3.4809 0 Td
(Fullerton,)Tj
4.1442 0 Td
(USA\))Tj
2.4548 0 Td
(on)Tj
1.2756 0 Td
(line)Tj
1.7064 0 Td
(coupled)Tj
3.3903 0 Td
(to)Tj
1.0261 0 Td
(a)Tj
0.6576 0 Td
(MicroTOF)Tj
4.5638 0 Td
(MS)Tj
1.5874 0 Td
(\(Bruker,)Tj
3.5603 0 Td
(Bre-)Tj
-35.07 -1.3039 Td
(men,)Tj
2.2336 0 Td
(Germany\))Tj
4.3313 0 Td
(described)Tj
4.0479 0 Td
(previously)Tj
4.354 0 Td
(in)Tj
1.0375 0 Td
(detail)Tj
2.4151 0 Td
([)Tj
0.83 0.64 0.02 0 k
(13)Tj
0 g
(].)Tj
2.0749 0 Td
(Accuracy,)Tj
4.1896 0 Td
(precision,)Tj
4.1329 0 Td
(selectivity,)Tj
4.3596 0 Td
(sensitivity,)Tj
-33.1764 -1.2983 Td
(reproducibility,)Tj
6.4232 0 Td
(and)Tj
1.7291 0 Td
(stability)Tj
3.3506 0 Td
(of)Tj
1.0148 0 Td
(the)Tj
1.474 0 Td
(CE-MS)Tj
3.1691 0 Td
(method)Tj
3.3222 0 Td
(have)Tj
2.0636 0 Td
(been)Tj
2.1203 0 Td
(previously)Tj
4.3483 0 Td
(described)Tj
4.0535 0 Td
([)Tj
0.83 0.64 0.02 0 k
(14)Tj
0 g
(].)Tj
2.0806 0 Td
(To)Tj
-35.1493 -1.2983 Td
(normalize)Tj
4.2462 0 Td
(for)Tj
1.389 0 Td
(variability)Tj
4.2236 0 Td
(in)Tj
1.0318 0 Td
(urinary)Tj
3.1975 0 Td
(output,)Tj
3.1237 0 Td
(a)Tj
0.652 0 Td
(set)Tj
1.3039 0 Td
(of)Tj
1.0148 0 Td
(29)Tj
1.1679 0 Td
(internal)Tj
3.3618 0 Td
(standard)Tj
3.7191 0 Td
(peptides)Tj
3.5546 0 Td
(were)Tj
2.126 0 Td
(used)Tj
2.0579 0 Td
(for)Tj
-36.1698 -1.3039 Td
(calibration,)Tj
4.7451 0 Td
(as)Tj
1.0205 0 Td
(previously)Tj
4.3483 0 Td
(described)Tj
4.0535 0 Td
([)Tj
0.83 0.64 0.02 0 k
(15)Tj
0 g
(].)Tj
2.075 0 Td
(Relative)Tj
3.3902 0 Td
(abundance)Tj
4.5921 0 Td
(of)Tj
1.0148 0 Td
(all)Tj
1.1452 0 Td
(peptides)Tj
3.5603 0 Td
(in)Tj
1.0318 0 Td
(a)Tj
0.6576 0 Td
(sample)Tj
3.0217 0 Td
(is)Tj
-34.6561 -1.2982 Td
(assessed)Tj
3.4695 0 Td
(based)Tj
2.4718 0 Td
(on)Tj
1.2756 0 Td
(the)Tj
1.474 0 Td
(peak)Tj
2.092 0 Td
(area,)Tj
2.1033 0 Td
(and)Tj
1.7348 0 Td
(normalized)Tj
4.7735 0 Td
(to)Tj
1.0261 0 Td
(the)Tj
1.4683 0 Td
(29)Tj
1.1736 0 Td
(standard)Tj
3.7247 0 Td
(peptides)Tj
3.5546 0 Td
([)Tj
0.83 0.64 0.02 0 k
(15)Tj
0 g
(].)Tj
2.075 0 Td
(This)Tj
1.9899 0 Td
(proce-)Tj
-34.4067 -1.2983 Td
(dure)Tj
2.0692 0 Td
(has)Tj
1.5421 0 Td
(been)Tj
2.1203 0 Td
(applied)Tj
3.1577 0 Td
(successfully)Tj
4.8643 0 Td
(in)Tj
1.0318 0 Td
(multiple)Tj
3.5659 0 Td
(previous)Tj
3.651 0 Td
(studies,)Tj
3.2145 0 Td
(some)Tj
2.3301 0 Td
(based)Tj
2.4718 0 Td
(on)Tj
1.2755 0 Td
(between)Tj
3.5263 0 Td
(1000)Tj
-34.8205 -1.2983 Td
(and)Tj
1.7291 0 Td
(over)Tj
1.9785 0 Td
(10000)Tj
2.5966 0 Td
(individual)Tj
4.2859 0 Td
(samples)Tj
3.3846 0 Td
([)Tj
0.83 0.64 0.02 0 k
(16)Tj
0 g
(,)Tj
0.83 0.64 0.02 0 k
(17)Tj
0 g
(].)Tj
3.2541 0 Td
(All)Tj
1.3947 0 Td
(detected)Tj
3.5659 0 Td
(peptides)Tj
3.5546 0 Td
(were)Tj
2.126 0 Td
(deposited,)Tj
4.2973 0 Td
(matched,)Tj
3.9005 0 Td
(and)Tj
-36.0678 -1.3039 Td
(annotated)Tj
4.2406 0 Td
(in)Tj
1.0318 0 Td
(a)Tj
0.6576 0 Td
(MicrosoftSQL)Tj
5.896 0 Td
(database)Tj
3.6397 0 Td
([)Tj
0.83 0.64 0.02 0 k
(9)Tj
0 g
(],)Tj
1.5987 0 Td
(allowing)Tj
3.617 0 Td
(for)Tj
1.389 0 Td
(further)Tj
3.0273 0 Td
(analysis)Tj
3.3279 0 Td
(and)Tj
1.7291 0 Td
(comparison)Tj
-30.1547 -1.2983 Td
(between)Tj
3.5262 0 Td
(groups.)Tj
3.1975 0 Td
(Sequencing)Tj
4.8302 0 Td
(of)Tj
1.0148 0 Td
(target)Tj
2.5115 0 Td
(peptides)Tj
3.5546 0 Td
(was)Tj
1.6951 0 Td
(performed)Tj
4.473 0 Td
(as)Tj
1.0148 0 Td
(described)Tj
4.0536 0 Td
([)Tj
0.83 0.64 0.02 0 k
(18)Tj
0 g
(],)Tj
2.0749 0 Td
(using)Tj
2.3868 0 Td
(Dionex)Tj
-34.333 -1.2982 Td
(Ultimate)Tj
3.7417 0 Td
(3000)Tj
2.1203 0 Td
(RSLS)Tj
2.3357 0 Td
(nano)Tj
2.2564 0 Td
(flow)Tj
1.9445 0 Td
(system)Tj
2.9367 0 Td
(\(Dionex,)Tj
3.736 0 Td
(Camberly)Tj
4.1386 0 Td
(UK\))Tj
1.9672 0 Td
(and)Tj
1.7348 0 Td
(a)Tj
0.652 0 Td
(Beckman)Tj
3.9458 0 Td
(CE,)Tj
1.6781 0 Td
(coupled)Tj
3.3902 0 Td
(to)Tj
-36.578 -1.3039 Td
(an)Tj
1.2018 0 Td
(Orbitrap)Tj
3.7304 0 Td
(Velos)Tj
2.4548 0 Td
(MS)Tj
1.5874 0 Td
(instrument)Tj
4.6828 0 Td
(\(Thermo)Tj
3.8211 0 Td
(Scientific\).)Tj
4.4673 0 Td
(To)Tj
1.338 0 Td
(assess)Tj
2.5228 0 Td
(the)Tj
1.4683 0 Td
(distribution)Tj
4.972 0 Td
(of)Tj
1.0148 0 Td
(peptides)Tj
-33.2615 -1.2983 Td
(in)Tj
1.0318 0 Td
(the)Tj
1.474 0 Td
(context)Tj
3.1804 0 Td
(of)Tj
1.0148 0 Td
(CKD,)Tj
2.5228 0 Td
(previously)Tj
4.3483 0 Td
(generated)Tj
4.1386 0 Td
(datasets)Tj
3.3562 0 Td
([)Tj
0.83 0.64 0.02 0 k
(8)Tj
0 g
(])Tj
1.372 0 Td
(were)Tj
2.1259 0 Td
(employed.)Tj
4.3654 0 Td
(The)Tj
1.7801 0 Td
(clinical)Tj
3.0784 0 Td
(and)Tj
-33.7887 -1.2983 Td
(demographic)Tj
5.5048 0 Td
(data)Tj
1.9105 0 Td
(of)Tj
1.0148 0 Td
(this)Tj
1.6781 0 Td
(cohort)Tj
2.8517 0 Td
(are)Tj
1.4513 0 Td
(available)Tj
3.6623 0 Td
(from)Tj
2.2054 0 Td
(the)Tj
1.474 0 Td
(original)Tj
3.3222 0 Td
(publication)Tj
4.7678 0 Td
([)Tj
0.83 0.64 0.02 0 k
(8)Tj
0 g
(].)Tj
ET
Q
q
1 j
1 J
0 w
11.9999 0 0 11.9999 200.0125 139.011 cm
BT
/F0 1 Tf
1 TL
-0.0033 Tc
0 0 Td
(Combining)Tj
4.937 0 Td
(peptides)Tj
3.9496 0 Td
(into)Tj
1.8095 0 Td
(a)Tj
0.7654 0 Td
(classifier)Tj
ET
Q
q
1 j
1 J
0 w
10 0 0 10 200.0125 122.0031 cm
BT
/F7 1 Tf
1 TL
-0.004 Tc
0 0 Td
(To)Tj
1.3379 0 Td
(generate)Tj
3.6056 0 Td
(a)Tj
0.6577 0 Td
(peptide)Tj
3.1918 0 Td
(pattern)Tj
3.1124 0 Td
(indicative)Tj
4.1329 0 Td
(of)Tj
1.0148 0 Td
(the)Tj
1.4683 0 Td
(impact)Tj
2.982 0 Td
(of)Tj
1.0148 0 Td
(empogliflazin,)Tj
5.8847 0 Td
(the)Tj
1.4684 0 Td
(support)Tj
3.3221 0 Td
(vector)Tj
-33.1934 -1.2982 Td
(machine)Tj
3.6623 0 Td
(\(SVM\)-based)Tj
5.5672 0 Td
(MosaCluster)Tj
5.3064 0 Td
(software)Tj
3.5887 0 Td
([)Tj
0.83 0.64 0.02 0 k
(19)Tj
0 g
(])Tj
1.8481 0 Td
(was)Tj
1.7008 0 Td
(employed.)Tj
4.3653 0 Td
(MosaCluster)Tj
5.3065 0 Td
(\(version)Tj
3.4922 0 Td
(1.7.0\))Tj
-34.8375 -1.3039 Td
(was)Tj
1.6951 0 Td
(developed)Tj
4.2746 0 Td
(for)Tj
1.3833 0 Td
(discrimination)Tj
6.1284 0 Td
(between)Tj
3.532 0 Td
(different)Tj
3.6567 0 Td
(patient)Tj
3.0047 0 Td
(groups)Tj
2.9707 0 Td
(in)Tj
1.0318 0 Td
(the)Tj
1.474 0 Td
(high-dimensional)Tj
-29.1513 -1.2983 Td
(parameter)Tj
4.3143 0 Td
(space)Tj
2.3754 0 Td
(by)Tj
1.1848 0 Td
(using)Tj
2.3868 0 Td
(SVM)Tj
2.2847 0 Td
(learning.)Tj
3.7474 0 Td
(SVM)Tj
2.2847 0 Td
(generates)Tj
3.9685 0 Td
(high)Tj
2.0069 0 Td
(dimensional)Tj
5.1704 0 Td
(models,)Tj
3.3335 0 Td
(which)Tj
2.6475 0 Td
(rely)Tj
ET
Q
q
1 j
1 J
0 w
576 737.1 m
36 737.1 l
36 737.6 l
576 737.6 l
f*
36 741.2598 107.1496 23.6976 re
W* n
q
107.0929 0 0 23.6409 36 741.3165 cm
q
/I0 Do
Q
Q
Q
q
0 0 612 792 re
W* n
1 j
1 J
0 w
7.9999 0 0 7.9999 420.4346 745.7952 cm
BT
/F0 1 Tf
1 TL
-0.005 Tc
0 0 Td
(Empaglifloz)Tj
5.074 0 Td
(in)Tj
0.978 0 Td
(impact)Tj
3.1181 0 Td
(on)Tj
1.311 0 Td
(the)Tj
1.5874 0 Td
(urinary)Tj
3.2174 0 Td
(proteome)Tj
ET
Q
q
1 j
1 J
0 w
36 48.0002 m
576 48.0002 l
576 47.5002 l
36 47.5002 l
f*
0.83 0.64 0.02 0 k
81.5811 34.9228 m
237.8835 34.9228 l
h
f*
0 g
7.9999 0 0 7.9999 36 36 cm
BT
/F0 1 Tf
1 TL
-0.005 Tc
0 0 Td
(PLOS)Tj
2.8559 0 Td
(ONE)Tj
2.3669 0 Td
(|)Tj
0.83 0.64 0.02 0 k
0.4748 0 Td
(https://doi.or)Tj
5.4142 0 Td
(g/10.137)Tj
3.8198 0 Td
(1/journal.po)Tj
5.1236 0 Td
(ne.01869)Tj
4.089 0 Td
(10)Tj
0 g
2.0906 0 Td
(October)Tj
3.7276 0 Td
(30,)Tj
1.5874 0 Td
(2017)Tj
33.5908 0 Td
(2)Tj
0.7654 0 Td
(/)Tj
0.496 0 Td
(12)Tj
/F9 1 Tf
-0.025 Tc
-66.402 84.0904 Td
(events)Tj
2.6362 0 Td
(from)Tj
2.0055 0 Td
(Janssen)Tj
3.2741 0 Td
(and)Tj
1.5945 0 Td
(Boehringe)Tj
3.7559 0 Td
(r)Tj
0.5315 0 Td
(Ingelheim,)Tj
-13.7977 -1.3748 Td
(has)Tj
1.5378 0 Td
(served)Tj
2.6858 0 Td
(as)Tj
1.063 0 Td
(an)Tj
1.1126 0 Td
(advisor)Tj
2.9339 0 Td
(for)Tj
1.2543 0 Td
(Boehringer)Tj
4.2875 0 Td
(Ingelheim,)Tj
-14.8749 -1.3749 Td
(and)Tj
1.5874 0 Td
(his)Tj
1.311 0 Td
(research)Tj
3.4158 0 Td
(institute)Tj
3.1606 0 Td
(has)Tj
1.5378 0 Td
(received)Tj
3.2953 0 Td
(research)Tj
-14.3079 -1.3748 Td
(grants)Tj
2.5724 0 Td
(on)Tj
1.1693 0 Td
(his)Tj
1.304 0 Td
(behalf)Tj
2.459 0 Td
(from)Tj
2.0126 0 Td
(Boehringer)Tj
4.2875 0 Td
(Ingelheim.)Tj
-13.8048 -1.3748 Td
(The)Tj
1.5874 0 Td
(funder)Tj
2.622 0 Td
(provided)Tj
3.4583 0 Td
(support)Tj
3.0969 0 Td
(in)Tj
0.8858 0 Td
(the)Tj
1.3748 0 Td
(form)Tj
2.0056 0 Td
(of)Tj
0.9496 0 Td
(salaries)Tj
-15.9804 -1.3748 Td
(for)Tj
1.2543 0 Td
(author)Tj
2.6291 0 Td
(HM,)Tj
1.7859 0 Td
(but)Tj
1.4173 0 Td
(did)Tj
1.3607 0 Td
(not)Tj
1.4244 0 Td
(have)Tj
1.9559 0 Td
(any)Tj
1.5378 0 Td
(additional)Tj
3.7914 0 Td
(role)Tj
-17.1568 -1.3748 Td
(in)Tj
0.8858 0 Td
(the)Tj
1.3677 0 Td
(study)Tj
2.2677 0 Td
(design,)Tj
2.8985 0 Td
(data)Tj
1.7929 0 Td
(collection)Tj
3.7418 0 Td
(and)Tj
1.5874 0 Td
(analysis,)Tj
-14.5418 -1.3748 Td
(decision)Tj
3.2882 0 Td
(to)Tj
0.9496 0 Td
(publish,)Tj
3.1465 0 Td
(or)Tj
0.9992 0 Td
(preparation)Tj
4.4433 0 Td
(of)Tj
0.9496 0 Td
(the)Tj
-13.7764 -1.3748 Td
(manuscript.)Tj
4.6417 0 Td
(The)Tj
1.5874 0 Td
(specific)Tj
3.019 0 Td
(roles)Tj
2.0338 0 Td
(of)Tj
0.9496 0 Td
(these)Tj
2.2111 0 Td
(authors)Tj
3.0473 0 Td
(are)Tj
-17.4899 -1.3748 Td
(articulated)Tj
4.0535 0 Td
(in)Tj
0.8929 0 Td
(the)Tj
1.3678 0 Td
(`author)Tj
2.8134 0 Td
(contributions')Tj
5.3008 0 Td
(section.)Tj
/F8 1 Tf
-14.4284 -2.1261 Td
(Competing)Tj
4.3795 0 Td
(interests)Tj
3.3307 0 Td
(:)Tj
/F9 1 Tf
0.4819 0 Td
(DC)Tj
1.3323 0 Td
(has)Tj
1.5308 0 Td
(received)Tj
3.3023 0 Td
(consulting)Tj
-14.3575 -1.3748 Td
(fees)Tj
1.7362 0 Td
(or)Tj
1.0063 0 Td
(speakin)Tj
2.8205 0 Td
(g)Tj
0.6945 0 Td
(honorarium)Tj
4.5709 0 Td
(or)Tj
0.9992 0 Td
(both)Tj
1.8992 0 Td
(from)Tj
-13.7268 -1.3748 Td
(Janssen,)Tj
3.5008 0 Td
(Boehringer)Tj
4.2874 0 Td
(Ingelheim-E)Tj
4.4363 0 Td
(li)Tj
0.6094 0 Td
(Lilly,)Tj
-12.8339 -1.3748 Td
(AstraZeneca)Tj
4.5638 0 Td
(,)Tj
0.4464 0 Td
(Merck,)Tj
2.7638 0 Td
(Sanofi,)Tj
2.7922 0 Td
(and)Tj
1.5874 0 Td
(his)Tj
1.3039 0 Td
(institution)Tj
3.8835 0 Td
(has)Tj
-17.341 -1.3748 Td
(received)Tj
3.3023 0 Td
(operating)Tj
3.7135 0 Td
(funding)Tj
3.033 0 Td
(from)Tj
2.0127 0 Td
(Janssen,)Tj
-12.0615 -1.3748 Td
(Boehringer)Tj
4.2874 0 Td
(Ingelheim-Eli)Tj
5.0457 0 Td
(Lilly,)Tj
1.9205 0 Td
(AstraZen)Tj
3.2953 0 Td
(eca,)Tj
1.715 0 Td
(Merck.)Tj
-16.2639 -1.3748 Td
(HM)Tj
1.559 0 Td
(is)Tj
0.8362 0 Td
(the)Tj
1.3678 0 Td
(co-founder)Tj
4.3016 0 Td
(and)Tj
1.5874 0 Td
(co-owner)Tj
3.7418 0 Td
(of)Tj
0.9496 0 Td
(Mosaique)Tj
3.6283 0 Td
(s)Tj
-17.9717 -1.3748 Td
(Diagnostic)Tj
3.9118 0 Td
(s,)Tj
0.8646 0 Td
(and)Tj
1.5945 0 Td
(employe)Tj
3.1535 0 Td
(d)Tj
0.6945 0 Td
(by)Tj
1.1126 0 Td
(Mosaiques)Tj
-11.3315 -1.3749 Td
(Diagnostic)Tj
3.9118 0 Td
(s.)Tj
0.8646 0 Td
(BAP)Tj
1.8 0 Td
(has)Tj
1.5378 0 Td
(received)Tj
3.2953 0 Td
(fees)Tj
1.7433 0 Td
(for)Tj
1.2544 0 Td
(continuing)Tj
-14.4072 -1.3748 Td
(medical)Tj
3.0968 0 Td
(education)Tj
3.8268 0 Td
(events)Tj
2.6363 0 Td
(from)Tj
2.0055 0 Td
(Janssen)Tj
3.274 0 Td
(and)Tj
-14.8394 -1.3748 Td
(Boehringer)Tj
4.2874 0 Td
(Ingelheim,)Tj
4.1032 0 Td
(has)Tj
1.5378 0 Td
(served)Tj
2.6858 0 Td
(as)Tj
1.063 0 Td
(an)Tj
1.1126 0 Td
(advisor)Tj
2.9339 0 Td
(for)Tj
-17.7237 -1.3748 Td
(Boehringer)Tj
4.2874 0 Td
(Ingelheim,)Tj
4.1032 0 Td
(and)Tj
1.5874 0 Td
(his)Tj
1.311 0 Td
(research)Tj
3.4158 0 Td
(institute)Tj
-14.7048 -1.3748 Td
(has)Tj
1.5378 0 Td
(received)Tj
3.3023 0 Td
(research)Tj
3.4158 0 Td
(grants)Tj
2.5725 0 Td
(on)Tj
1.1622 0 Td
(his)Tj
1.311 0 Td
(behalf)Tj
2.4591 0 Td
(from)Tj
-15.7607 -1.3748 Td
(Boehringer)Tj
4.2874 0 Td
(Ingelheim.)Tj
4.1032 0 Td
(All)Tj
1.1338 0 Td
(other)Tj
2.1473 0 Td
(authors)Tj
3.0473 0 Td
(have)Tj
1.9559 0 Td
(no)Tj
-16.6749 -1.3819 Td
(conflict)Tj
2.9055 0 Td
(of)Tj
0.9496 0 Td
(interest)Tj
2.9693 0 Td
(to)Tj
0.9496 0 Td
(report.)Tj
2.6788 0 Td
(This)Tj
1.7858 0 Td
(does)Tj
2.0056 0 Td
(not)Tj
1.4244 0 Td
(alter)Tj
1.8213 0 Td
(our)Tj
-17.4899 -1.3748 Td
(adherence)Tj
4.0535 0 Td
(to)Tj
0.9496 0 Td
(PLOS)Tj
2.3316 0 Td
(ONE)Tj
1.8708 0 Td
(policies)Tj
3.0119 0 Td
(on)Tj
1.1622 0 Td
(sharing)Tj
2.9835 0 Td
(data)Tj
-16.3631 -1.3749 Td
(and)Tj
ET
endstream
endobj
38 0 obj
<>stream
endstream
endobj
39 0 obj
<>stream
endstream
endobj
40 0 obj
<>stream
endstream
endobj
41 0 obj
<>stream
endstream
endobj
42 0 obj
<>stream
endstream
endobj
43 0 obj
<>stream
endstream
endobj
44 0 obj
<>stream
endstream
endobj
45 0 obj
<>stream
endstream
endobj
46 0 obj
<>stream
endstream
endobj
47 0 obj
<>stream
endstream
endobj
48 0 obj
<>stream
endstream
endobj
49 0 obj
<>stream
endstream
endobj
50 0 obj
<>stream
endstream
endobj
51 0 obj
<>stream
endstream
endobj
52 0 obj
<>stream
endstream
endobj
53 0 obj
<>stream
endstream
endobj
54 0 obj
<>stream
endstream
endobj
55 0 obj
<>stream
endstream
endobj
56 0 obj
<>stream
BT
1.5874 47.5869 Td
(materials.)Tj
ET
Q
endstream
endobj
57 0 obj
<>/XObject<>>>/CropBox[0 0 612 792]/MediaBox[0 0 612 792]/Parent 12 0 R/Annots 60 0 R/Contents 61 0 R/TrimBox[0 0 612 792]>>
endobj
58 0 obj
<>
endobj
62 0 obj
<>
endobj
63 0 obj
<>stream
%!PS-AdobeFont-1.0
11 dict begin
/FontName /TeX_CM_Maths_Italic def
/FontType 1 def
/FontBBox {-31 -239 1041 750} readonly def
/FontMatrix [0.001 0 0 0.001 0 0] readonly def
/PaintType 0 def
/FontInfo 8 dict dup begin
/FullName (TeX_CM_Maths_Italic) readonly def
/BaseFontName (TeX_CM_Maths_Italic) def
end def
/Encoding 256 array
0 1 255 {1 index exch /.notdef put} for
dup 0 /C0 put
dup 1 /C1 put
dup 2 /C2 put
dup 3 /C3 put
dup 4 /C4 put
dup 5 /C5 put
dup 6 /C6 put
dup 7 /C7 put
dup 8 /C8 put
dup 9 /C9 put
dup 10 /C10 put
dup 11 /C11 put
dup 12 /C12 put
dup 13 /C13 put
dup 14 /C14 put
dup 15 /C15 put
dup 16 /C16 put
dup 17 /C17 put
dup 18 /C18 put
dup 19 /C19 put
dup 20 /C20 put
dup 21 /C21 put
dup 22 /C22 put
dup 23 /C23 put
dup 24 /C24 put
dup 25 /C25 put
dup 26 /C26 put
dup 27 /C27 put
dup 28 /C28 put
dup 29 /C29 put
dup 30 /C30 put
dup 31 /C31 put
dup 32 /space put
dup 33 /exclam put
dup 34 /quotedbl put
dup 35 /numbersign put
dup 36 /dollar put
dup 37 /percent put
dup 38 /ampersand put
dup 39 /quoteright put
dup 40 /parenleft put
dup 41 /parenright put
dup 42 /asterisk put
dup 43 /plus put
dup 44 /comma put
dup 45 /hyphen put
dup 46 /period put
dup 47 /slash put
dup 48 /zero put
dup 49 /one put
dup 50 /two put
dup 51 /three put
dup 52 /four put
dup 53 /five put
dup 54 /six put
dup 55 /seven put
dup 56 /eight put
dup 57 /nine put
dup 58 /colon put
dup 59 /semicolon put
dup 60 /less put
dup 61 /equal put
dup 62 /greater put
dup 63 /question put
dup 64 /at put
dup 65 /A put
dup 66 /B put
dup 67 /C put
dup 68 /D put
dup 69 /E put
dup 70 /F put
dup 71 /G put
dup 72 /H put
dup 73 /I put
dup 74 /J put
dup 75 /K put
dup 76 /L put
dup 77 /M put
dup 78 /N put
dup 79 /O put
dup 80 /P put
dup 81 /Q put
dup 82 /R put
dup 83 /S put
dup 84 /T put
dup 85 /U put
dup 86 /V put
dup 87 /W put
dup 88 /X put
dup 89 /Y put
dup 90 /Z put
dup 91 /bracketleft put
dup 92 /backslash put
dup 93 /bracketright put
dup 94 /asciicircum put
dup 95 /underscore put
dup 96 /quoteleft put
dup 97 /a put
dup 98 /b put
dup 99 /c put
dup 100 /d put
dup 101 /e put
dup 102 /f put
dup 103 /g put
dup 104 /h put
dup 105 /i put
dup 106 /j put
dup 107 /k put
dup 108 /l put
dup 109 /m put
dup 110 /n put
dup 111 /o put
dup 112 /p put
dup 113 /q put
dup 114 /r put
dup 115 /s put
dup 116 /t put
dup 117 /u put
dup 118 /v put
dup 119 /w put
dup 120 /x put
dup 121 /y put
dup 122 /z put
dup 123 /braceleft put
dup 124 /bar put
dup 125 /braceright put
dup 126 /asciitilde put
dup 127 /Euro put
readonly def
currentdict end
currentfile eexec
M#1H5 J6o\&rtS(#v\0\V7Fe༙OYx5-cY9^%Y6
(efIOldN"wȰ;)UƽoFg/rvV$JS8_oc@
o9-eGJp}[Do]mN=4*{ܯq=eU^t6¤.vA2*Sr 2@Y0}Rcx,TX|ZP
;o<[1?
T<=qo:-62/]8~i wX?wJ`lLkI@EjYׅq5ڧHtvc6i 0M]YUN;M]ť0]z[{s1uO[6be#9k~d/YpMA.=뤎P\|W#?W$iz81ZL
Ңri^?WP]X A.@
z[
75y6k .U*3}hA\t&HW!Q
=+Г A 5